Is UNII-207SMY3FQT Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-207SMY3FQT? Is UNII-207SMY3FQT safe for nursing mother and child? Does UNII-207SMY3FQT extracts into breast milk? Does UNII-207SMY3FQT has any long term or short term side effects on infants? Can UNII-207SMY3FQT influence milk supply or can UNII-207SMY3FQT decrease milk supply in lactating mothers?
Answer by DrLact: About UNII-207SMY3FQT usage in lactation
No information is available on the clinical use of UNII-207SMY3FQT during breastfeeding. Because UNII-207SMY3FQT is more than 99% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is 57 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during UNII-207SMY3FQT therapy and for 2 weeks after the final dose.
Alternate Drugs
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Letrozole(Dangerous)
Mitoxantrone(Dangerous)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mercaptopurine(Safe)
Cladribine(Dangerous)
Nivolumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Ipilimumab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Cetuximab(Unsafe)
Doxorubicin(Dangerous)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Paclitaxel(Dangerous)
Cisplatin(Unsafe)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Fluorouracil(Dangerous)
Busulfan(Dangerous)
Docetaxel(Dangerous)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Rituximab(Low Risk)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Bevacizumab(Low Risk)
Allopurinol(Safe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)